Membership
Our Members
EMIG has over 250 member companies and organisations - including Associate Members e.g., companies providing essential support services to the life sciences ecosystem. Patient Charities, research policy organisations and universities enjoy free membership.
Collectively, we represent the breadth of the health and medicines ecosystem, which means EMIG has become a platform for greater knowledge and ideas exchange.
The extensive knowledge and experience of the people in our Membership constitutes our Network and we use the Network to help our Members as they need it.
For Members
Each EMIG Member has an equal voice in representation and determining policy. No problem is too big or too small because we are not just an association, we are a network.
Our 13 special interest groups reflect EMIG's primary areas of focus, determined by our members. These are the vehicles for networking, information exchange, and policy development.
They complement our Quarterly Meetings where c. 140 members meet to hear prominent speakers address the issues of the day.
What is the EMIG platform?
Our exclusive platform enhances your membership with a personalised dashboard that provides easy access to:
Network
Submit questions/requests anonymously to the Network and receive curated responses, or search the directory for previously asked questions
Events
View and register for upcoming events by interest group, track your personal event schedule, and join live sessions directly through the platform
Resources
Quick access to documents, videos, and podcasts
Maximise your membership benefits with EMIG Online
Featured Events
Below are upcoming events that may be relevant to EMIG members, register your attendance now.
Where to start on sustainability?
Zoom WebinarHosted by: ExternalAgenda: Join us for the first in a series of four interactive, invite-only roundtables designed specifically for pharma decision-makers and professionals who want to deepen their sustainability impact. This meeting is being organised by the law firm, VWV and so any queries should be addressed to them. Contact details are on the registration page.
EMIG Quarterly Meeting
London
Hosted by: EMIGAgenda: A varied agenda, featuring the VPAG negotiations, NHS 10 Year Plan Update + ICB/commissioning/NHSE Update, Government Policy update and a panel session with a health system expert panel discussing NHS the NHS 10-year plan, balancing the present with the future, and the realities for life sciences.
EMIG Women in Pharma Webinar
Zoom WebinarHosted by: EMIGAgenda: Our guest speaker, Hannah Collison will be speaking about Resilience, what it is and what can we do to develop our own resilience.
EMIG Wales Webinar
Zoom WebinarHosted by: EMIGAgenda: Power Shift: Why Election ’26 Will Bring New Risks and Opportunities for Organisations in Wales. The presentation explores the significant political change with the election of a new Welsh Parliament with more members, elected under a different electoral process, what it means for the political parties, and the shape of the next Welsh Government.
Featured Network Questions
Tap into the collective expertise of the EMIG network. Browse recent questions and curated responses, or submit your own inquiries to connect with industry peers.
I'm looking for recommendations for organisations that support companies with tender responses
We are looking for a warehouse company where we can stock and distribute stock and samples for our field team
I’m seeking peer input on MHRA’s interpretation of the “Contract Giver” requirement in Part C of the QP Declaration following the April 2025 EMA Q&A update (EMA/129980/2025)
How are companies processing their TOV / Disclosure data?
Featured Resources
Our resources library offers easy access to useful materials including presentations, documents, videos and podcasts. The resources are organised by most recent date upload but you can sort, filter and search by the name of the event, category or file type.
NICE
NICE's new drug approval removal policy
Government
Richard Williams VPAG June Newsletter
